Evidence for a genetic basis for altitude illness: 2010 update

High Altitude Medicine and Biology

Volumn 11, Issue 4, 2010, Pages 349-368

  MacInnis, Martin J ^a   Koehle, Michael S ^a   Rupert, Jim L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

acute mountain sickness; AMS; CMS; genetic epidemiology; HACE; HAPE; HAPH

Indexed keywords

ALTITUDE; ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; ARTICLE; BRAIN EDEMA; CLIMBING; DISEASE PREDISPOSITION; EPIGENETICS; GENETIC SUSCEPTIBILITY; HERITABILITY; HUMAN; HYPOXIA; LUNG EDEMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ABO BLOOD-GROUP SYSTEM; ACCLIMATIZATION; ALDOSTERONE SYNTHASE; ALLELES; ALTITUDE SICKNESS; ANGIOTENSINOGEN; APOLIPOPROTEINS B; ENDOTHELINS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; GLUTATHIONE TRANSFERASE; HEAT-SHOCK PROTEINS; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOUNTAINEERING; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDYL-DIPEPTIDASE A; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, BRADYKININ B2; RECEPTORS, ADRENERGIC, BETA-2; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 78650762190     PISSN: 15270297     EISSN: None     Source Type: Journal    
DOI: 10.1089/ham.2010.1030     Document Type: Article

References (120)

1. Aguilera O., Fernande A.F., Munoz A., and Fraga M.F. (2010). Epigenetics and environment: A complex relationship. J. Appl. Physiol. 109:243-251.
2. Ahsan A., Charu R., Pasha M.A., Norboo T., Charu R., Afrin F., Ahsan A., and Baig M.A. (2004). eNOS allelic variants at the same locus associate with HAPE and adaptation. Thorax. 59:1000-1002.
3. Aldashev A.A. (2000). High-altitude pulmonary hypertension and signal transduction in the cardiovascular system. J. Receptor Signal Transduction Res. 20:255-278.
4. Aldashev A.A. (2007). Gene polymorphisms and high altitude pulmonary hypertension. In Problems of High Altitude Medicine and Biology. A. A. Aldashev and R. Naeije, eds. Springer, New York; pp. 151-168.
5. Aldashev A.A., Sarybaev A.S., Sydykov A.S., Kalmyrzaev B.B., Kim E.V., Mamanova L.B., Maripov R., Kojonazarov B.K., Mirrakhimov M.M., Wilkins M.R., et al. (2002). Characterization of high-altitude pulmonary hypertension in the Kyrgyz: Association with angiotensin-converting enzyme genotype. Am. J. Respir. Crit. Care Med. 166:1396-1402.
6. Ates N.A., Tamer L., Ates C., Ercan B., Elipek T., Ocal K., and Camdeviren H. (2005). Glutathione S-transferase M1, T1, P1 genotypes and risk for development of colorectal cancer. Biochem. Genet. 43:149-163. (Pubitemid 40543712)
7. Attia J., Ioannidis J.P., Thakkinstian A., McEvoy M., Scott R.J., Minelli C., Thompson J., Infante- Rivard C., and Guyatt G. (2009a). How to use an article about genetic association: A: background concepts. JAMA. 301:74-81.
8. Attia J., Ioannidis J.P., Thakkinstian A., McEvo M., Scott R.J., Minell, C., Thompson J., Infante- Rivard C., and Guyatt,G. (2009b). How to use an article about genetic association: B: Are the results of the study valid? JAMA. 301:191-197.
9. Attia J., Ioannidis, J.P., Thakkinstian A., McEvoy M., Scott R.J., Minelli C., Thompson J., Infante- Rivard C., and Guyatt G. (2009c). How to use an article about genetic association: C: What are the results and will they help me in caring for my patients? JAMA. :301:304-308.
10. Bailey D.M., Bartsch P., Knauth M., and Baumgartner R.W. (2009). Emerging concepts in acute mountain sickness and high-altitude cerebral edema: From the molecular to the morphological. Cell Mol. Life Sci. 66:3583-3594.
11. Bartsch P., Bailey D.M., Berger M.M., Knauth M., and Baumgartner R.W. (2004). Acute mountain sickness: Controversies and advances. High Alt. Med. Biol. 5:110-124.
12. Bartsch P., Gruni, E., Hohenhaus E., and Dehnert C. (2001). Assessment of high altitude tolerance in healthy individuals. High Alt. Med. Biol. 2:287-296.
13. Bartsch P., and Saltin B. (2008). General introduction to altitude adaptation and mountain sickness. Scand. J. Med. Sci. Sports. 18 Suppl. 1:1-10.
14. Beall C.M. (2000). Tibetan and Andean patterns of adaptation to high-altitude hypoxia. Hum. Biol. 72:201-228.
15. Beall C.M., Cavalleri G.L., Deng L., Elston R.C., Gao Y., Knight J., Li C., Li J.C., Liang Y., McCormack M., et al. (2010). Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlanders. Proc. Natl. Acad. Sci. USA. 107:11459-11464.
16. Brown C.J., and Rupert J.L. (2010). Epigenetics and the potential role of epigenetic changes in hypoxia-induced gene expression. In Hypoxia and Exercise: Proceedings of the 16th International Hypoxia Symposium. R. C. Roach, P. D. Wagner, and P. H. Hackett, eds. Springer, New York; [in press.]
17. Buroker N.E., Ning X.H., Zhou Z.N., Li K., Cen W.J., Wu X.F., Ge M., Fan L.P., Zhu W.Z., Portman M.A., and Chen S.H. (2010). Genetic associations with mountain sickness in Han and Tibetan residents at the Qinghai-Tibetan Plateau. Clin. Chim. Acta. 411:1466-1473.
18. Charu R., Stobdan T., Ram R.B., Khan A.P., Qadar Pasha M.A., Norboo T., and Afrin F. (2006). Susceptibility to high altitude pulmonary oedema: Role of ACE and ET-1 polymorphisms. Thorax. 61:1011-1012.
19. Chung C.M., Wang R.Y., Chen J.W., Fann C.S., Leu H.B., Ho H.Y., Ting C.T., Lin T.H., Sheu S.H., Tsai W.C., et al. (2010). A genome-wide association study identifies new loci for ACE activity: Potential implications for response to ACE inhibitor. Pharmacogenomics J. Jan. 12. [Epub ahead of print].
20. Cockcroft J.R., Gazis A.G., Cross D.J., Wheatley A., Dewar J., Hall I.P., and Noon J.P. (2000). Beta(2)-adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension. 36:371-375.
21. Cordell H.J. (2009). Detecting gene-gene interactions that underlie human diseases. Nat. Rev. Genet. 10:392-404.
22. Dehnert C., Berger M.M., Mairbaurl H., and Bartsch P. (2007). High altitude pulmonary edema: A pressure-induced leak. Respir. Physiol. Neurobiol. 158:266-273.
23. Dehnert C., Grunig E., Mereles D., von Lennep N., and Bartsch P. (2005). Identification of individuals susceptible to highaltitude pulmonary oedema at low altitude. Eur. Respir. J. 25:545-551.
24. Dehnert C., Weymann J., Montgomery H.E., Woods D., Maggiorin, M., Scherrer U., Gibbs J.S., and Bartsch P. (2002). No association between high-altitude tolerance and the ACE I/D gene polymorphism. Med. Sci. Sports Exerc. 34:1928-1933.
25. Dorward D.A., Thompson A.A., Baillie J.K., MacDougall M., and Hirani N. (2007). Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness. Respir. Med. 101:587-594.
26. Droma Y., Hanaoka M., Hotta J., Katsuyama Y., Ota M., Kobayashi T., and Kubo K. (2003). The r506 Q mutation of coagulation factor V gene in high altitude pulmonary-edemasusceptible subjects. High Alt. Med. Biol. 4:497-498.
27. Droma Y., Hanaoka M., Ota M., Katsuyama Y., Koizuma T., Fujimoto K., Kobayashi T., and Kubo K. (2002). Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation. 106:826-830.
28. Droma Y., Ota M., Hanaoka M., Katsuyama Y., Basnyat B., Neupan, P., Arjyal A., Pandit A., Sharma D., Ito M., et al. (2008). Two hypoxia sensor genes and their association with symptoms of acute mountain sickness in Sherpas. Aviat. Space Environ. Med. 79:1056-1060.
29. Eddahibi S., Hanoun N., Lanfumey L., Lesch K.P., Raffestin B., Hamon M., and Adnot S. (2000). Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J. Clin. Invest. 105:1555-1562.
30. Fatini C., Abbate R., Pepe G., Battaglini B., Gensini F., Ruggiano G., Gensini G.F., and Guazzelli R. (2000). Searching for a better assessment of the individual coronary risk profile: The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms. Eur. Heart J. 21:633-638.
31. Fred H., Schmidt A., Bates T., and Hecht H. (1962). Acute pulmonary edema of altitude. Circulation. 25:929-937.
32. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans, L.A., van den Heuvel L.P., et al. (1995). A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10:111-113.
33. Fumeron F., Betoulle D., Nicaud V., Evans A., Kee F., Ruidavets J.B., Arveiler D., Luc G., and Cambien F. (2002). Serotonin transporter gene polymorphism and myocardial infarction: Etude Cas-Temoins de l'Infarctus du Myocarde (ECTIM). Circulation. 105:2943-2945.
34. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L., Baranova H., Bathum L., Benhamou S., Boffetta P., et al. (2001). Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 10:1239-1248.
35. Ge R.-L., and Helun H. (2001). Current concept of chronic mountain sickness: Pulmonary hypertension-related highaltitude heart disease. Wild Environ. Med. 12:190-194.
36. Gelfi C., De Palma S., RipamontiM., Eberin I., Wait R., Bajracharya A., Marconi C., Schneider A., Hoppeler H., and Cerretelli P. (2004). New aspects of altitude adaptation in Tibetans: A proteomic approach. Faseb. J. 18:612-614.
37. Gheorghe C.P., Mohan S., Oberg K.C., and Longo L.D. (2007). Gene expression patterns in the hypoxic murine placenta: A role in epigenesis? Reprod. Sci. 14:223-233.
38. Green S.A., Turki J., Innis M., and Liggett S.B. (1994). Aminoterminal polymorphisms of the human β2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry. 33:9414-9419.
39. Hanaoka M., Droma Y., Hotta J., Matsuzawa Y., Kobayashi T., Kubo K., and Ota M. (2003a). Polymorphisms of the tyrosine hydroxylase gene in subjects susceptible to high-altitude pulmonary edema. Chest. 123:54-58.
40. Hanaoka M., Droma Y., Ota M., Ito M., Katsuyama Y., and Kubo K. (2009). Polymorphisms of human vascular endothelial growth factor gene in high-altitude pulmonary oedema susceptible subjects. Respirology. 14:46-52.
41. Hanaoka M., Kubo K., Yamazaki Y., Miyahara T., Matsuzaw Y., Kobayashi T., Sekiguchi M., Ota M., and Watanabe H. (1998). Association of high-altitude pulmonary edema with the major histocompatibility complex. Circulation. 97:1124-1128.
42. Heijmans B.T., Tob E.W., Stein A.D., Putter H., Blauw G.J., Susser E.S., Slagboom P.E., and Lumey L.H. (2008). Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl. Acad. Sci. USA. 105:17046-17049.
43. Hirst M., and Marra M.A. (2009). Epigenetics and human disease. Int. J. Biochem. Cell Biol. 41:136-146.
44. Hotta J., Hanaoka M., Droma Y., Katsuyama Y., Ota M., and Kobayashi T. (2004). Polymorphisms of renin-angiotensin system genes with high-altitude pulmonary edema in Japanese subjects. Chest. 126: 825-830.
45. Hultgren H.N., Spickard W.B., Hellriegel K., and Houston C.S. (1961). High altitude pulmonary edema. Med. (Baltimore). 40:289-313.
46. Iwai M., and Horiuchi M. (2009). Devil and angel in the renin- angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens. Res. 32:533-536.
47. Jiang C.Z., Li F.Z., He M.A., Sun S.Y., Zhang S.Y., Liao R., Jia S.Y., Zeng H.S., and Wu T.C. (2005). [Glutathione S-transferase M1, T1 genotypes and the risk of mountain sickness]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 23:188-190.
48. Kallenberg K., Bailey D.M., Christ S., Mohr A., Roukens R., Menold E., Steiner T., Bartsch P., and Knauth M. (2007). Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness. J. Cereb. Blood Flow Metab. 27:1064-1071.
49. Kalson N.S., Thompson J., Davies A.J., Stokes S., Earl M.D., Whitehead A., Tyrrell-Marsh I., Frost H., and Montgomery, H. (2009). The effect of angiotensin-converting enzyme genotype on acute mountain sickness and summit success in trekkers attempting the summit of Mt. Kilimanjaro (5,895 m). Eur. J. Appl. Physiol. 105:373-379.
50. Kaner R.J., Ladetto J.V., Sing, R., Fukuda N., Matthay M.A., and Crystal R.G. (2000). Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am. J. Respir. Cell Mol. Biol. 22:657-664.
51. Kim H.S., Lee M.M., Oh B.H., Kim K.I., Han K.H., Park S.K., Sohn D.W., Yoo K.Y., Park Y.B., Choi Y.S., et al. (2000). Synergistic effect of angiotensin-converting enzyme and angiotensinogen gene on cardiac hypertrophy. Int. Cardiol. 72:151-161.
52. Koehle M.S., Wang P., Guenette J.A., and Rupert J.L. (2006). No association between variants in the ACE and angiotensin II receptor 1 genes and acute mountain sickness in Nepalese pilgrims to the Janai Purnima Festival at 4380 metres. High Alt. Med. Biol. 7:281-289.
53. Kumar R., Pasha Q., Khan A.P., and Gupta V. (2004). Renin angiotensin aldosterone system and ACE I/D gene polymorphism in high-altitude pulmonary edema. Aviat. Space Environ. Med. 75:981-983.
54. Lamon-Fava S., Jimenez D., Christian J.C., Fabsitz R.R., Reed T., Carmelli D., Castelli W.P., Ordovas J.M., Wilson P.W., and Schaefer E.J. (1991). The NHLBI Twin Study: Heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a). Atherosclerosis. 91:97-106.
55. Li F.Z., Zhou F., Jiang C.Z., Sun S.Y., He M.A., Zhang S.Y., Liao R., Zeng H.S., Wu Y.M., and Wu T.C. (2004). [Relationship between heat stress protein 70 gene polymorphisms and the risk of acute mountain sickness]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 22:413-415.
56. Lin Z.P., Yiao Q.Y., Miao C.Y., and Chen D.S. (1984). Family susceptibility to high altitude heart disease. In High Altitude Disease. Zhang Y.B., Wang Y., and Liu X.L., eds. Qinghai Press, Xining, China; pp. 268-287.
57. Loeppky J.A., Icenogle M.V., Maes D., Riboni K., Scotto P., and Roach R.C. (2003). Body temperature, autonomic responses, and acute mountain sickness. High Alt. Med. Biol. 4:367-373.
58. Lorenzo V.F., Yang Y., Simonson T.S., Nussenzvei, R., Jorde L.B., Prchal J.T., and Ge R.L. (2009). Genetic adaptation to extreme hypoxia: Study of high-altitude pulmonary edema in a threegeneration Han Chinese family. Blood Cells Mol. Dis. 43:221-225.
59. Maloney J., Wan, D., Duncan T., Voelkel N., and Ruoss S. (2000). Plasma vascular endothelial growth factor in acute mountain sickness. Chest. 118:47-52. (Pubitemid 30485488)
60. Mazzeo R.S., and Reeves J.T. (2003). Adrenergic contribution during acclimatization to high altitude: Perspectives from Pikes Peak. Exerc. Sport Sci. Rev. 31:13-18.
61. Mejia O.M., Prchal J.T., Leon-Velarde F., Hurtado A., and Stockton D.W. (2005). Genetic association analysis of chronic mountain sickness in an Andean high-altitude population. Haematologica. 90:13-19.
62. Misra M.K., Sarwat M., Bhakun, P., Tuteja R., and Tuteja N. (2009). Oxidative stress and ischemic myocardial syndromes. Med. Sci. Monitor. 15:RA209-RA219.
63. Moore J.H., and Williams S.M. (2009). Epistasis and its implications for personal genetics. Am. J. Hum. Genet. 85:309-320.
64. Moore L.G., Niermeyer S., and Zamudio, S. (1998). Human adaptation to high altitude: Regional and life-cycle perspectives. Am. J. Phys. Anthropol. Suppl 27:25-64.
65. Moore L.G., Shriver M., Bemis L., Hickler B., Wilson M., Brutsaert T., Parra E., and Vargas E. (2004). Maternal adaptation to high-altitude pregnancy: An experiment of nature: A review. Placenta. 25 Suppl A:S60-S71.
66. Morrell N.W., Sarybaev A.S., Alikhan A., Mirrakhimov M.M., and Aldashev A.A. (1999). ACE genotype and risk of high altitude pulmonary hypertension in Kyrghyz highlanders. Lancet. 353:814.
67. Nilles E., Sayward H., and D'Onofrio G. (2009). Vascular endothelial growth factor and acute mountain sickness. J. Emerg. Trauma Shock. 2:6-9.
68. Norboo T., Saiyed H.N., Angchuk P.T., Tsering P., Angchuk S.T., Phuntsog S.T., Yahya M., Wood S., Bruce N.G., and Ball K.P. (2004). Mini review of high altitude health problems in Ladakh. Biomed. Pharmacother. 58:220-225.
69. Palmer B.F. (2010). Physiology and pathophysiology with ascent to altitude. Am. J. Med. Sci. 340:69-77.
70. Qadar Pasha M.A., Charu R., Ahsan A., and Norboo T. (2005). HAPE susceptibility associates with variants of genes of vascular homeostasis. Human Genome Mapping; Genomic Basis of Common Diseases. Poster abstract 310.
71. Qi Y., Niu W., Zhu T., Zhou W., and Qiu C. (2008). Synergistic effect of the genetic polymorphisms of the renin-angiotensin- aldosterone system on high-altitude pulmonary edema: A study from Qinghai-Tibet altitude. Eur. J. Epidemiol. 23:143-152.
72. Qi Y., Niu W.Q., Zhu T.C., Liu J.L., Dong W.Y., Xu Y., Ding S.Q., Cui C.B., Pan Y.J., Yu G.S., et al. (2009). Genetic interaction of Hsp70 family genes polymorphisms with high-altitude pulmonary edema among Chinese railway constructors at altitudes exceeding 4000 meters. Clin. Chim. Acta. 405:17-22.
73. Rajput C., Arif E., Vibhuti A., Stobdan T., Khan A.P., Norboo T., Afrin F., and Qadar Pasha M.A. (2006). Predominance of interaction among wild-type alleles of CYP11B2 in Himalayan natives associates with high-altitude adaptation. Biochem. Biophys. Res. Commun. 348:735-740.
74. Reátegui L. (1969). Soroche crónico: Observaciones realizadas en el Cuzco en 30 casos. Rev. Peru Cardiol. 15:45-59 [in Spanish].
75. Ritchie M.D., Hahn L.W., Roodi N., Bailey L.R., Dupont W.D., Parl F.F., and Moore J.H. (2001). Multifactor-dimensionality reduction reveals high-order interactions among estrogenmetabolism genes in sporadic breast cancer. Am. J. Hum. Genet. 69:138-147.
76. Roach R.C., Loeppky J.A., and Icenogle M.V. (1996). Acute mountain sickness: Increased severity during simulated altitude compared with normobaric hypoxia. J. Appl. Physiol. 81:1908-1910.
77. Rockwell L.C., Vargas E., and Moore L.G. (2003). Human physiological adaptation to pregnancy: Inter- and intraspecific perspectives. Am. J. Hum. Biol. 15:330-341.
78. Rupert J.L., and Hochachka P.W. (2001). The evidence for hereditary factors contributing to high altitude adaptation in Andean natives: A review. High Alt. Med. Biol. 2:235-256.
79. Rupert J.L., and Koehle M.S. (2006). Evidence for a genetic basis for altitude-related illness. High Alt. Med. Biol. 7:150-167.
80. Sasabe E., Yang Z., Ohno S., and Yamamoto T. (2010). Reactive oxygen species produced by the knockdown of manganesesuperoxide dismutase up-regulate hypoxia-inducible factor- 1alpha expression in oral squamous cell carcinoma cells. Free Radical Biol. Med. 48:1321-1329.
81. Saxena S., Kumar R., Madan T., Gupta V., Muralidhar K., and Sarma, P.U. (2005). Association of polymorphisms in pulmonary surfactant protein A1 and A2 genes with high-altitude pulmonary edema. Chest. 128:1611-1619.
82. Scandalios J.G. (2005). Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Braz. J. Med. Biol. Res. 38:995-1014.
83. Schoene R.B. (2004). Unraveling the mechanism of high altitude pulmonary edema. High Alt. Med. Biol. 5:125-135.
84. Schoene R.B. (2008). Illnesses at high altitude. Chest. 134:402-416.
85. Schoonman G.G., Sandor P.S., Nirkko A.C., Lange T., Jaermann T., Dydak, U., Kremer C., Ferrari M.D., Boesiger P., and Baumgartner R.W. (2008). Hypoxia-induced acute mountain sickness is associated with intracellular cerebral edema: A 3 T magnetic resonance imaging study. J. Cereb. Blood Flow Metab. 28:198-206.
86. Scoggin C.H., Hyers T.M., Reeves J.T., and Grover R.F. (1977). High-altitude pulmonary edema in the children and young adults of Leadville, Colorado. N. Engl. J. Med. 297:1269-1272.
87. Semenza, G.L. (2007). Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007, cm8.
88. Sharp N.C. (2008). The human genome and sport, including epigenetics and athleticogenomics: A brief look at a rapidly changing field. J. Sports Sci. 26(11):1127-1133.
89. Siffert W. (2000). G protein beta 3 subunit 825T allele, hypertension, obesity, and diabetic nephropathy. Nephrol. Dial. Transplant. 15:1298-1306.
90. Simonson T.S., Yang Y., Huff C.D., Yun H., Qin G., Witherspoon D.J., Bai Z., Lorenzo F.R., Xing J., Jorde L.B., et al. (2010). Genetic evidence for high-altitude adaptation in Tibet. Science. 329:72-75.
91. Smith E.M., Baillie J.K., Thompson A.A., Irving J.B., Porteous D., and Webb D.J. (2006). Endothelial nitric oxide synthase polymorphisms do not influence pulmonary artery systolic pressure at altitude. High Alt. Med. Biol. 7:221-227.
92. Smith T.G., Robbins P.A., and Ratcliffe P.J. (2008). The human side of hypoxia-inducible factor. Br. J. Haematol. 141:325-334.
93. Stobdan T., Kumar R., Mohammad G., Thinlas T., Norboo T., Iqbal M., and Pasha M.A. (2010). Probable role of beta2- adrenergic receptor gene haplotype in high-altitude pulmonary oedema. Respirology. 15:651-658.
94. Storm van's Gravesande K., Wechsler M.E., Grasemann H., Silverman E.S., Le L., Palmer L.J., and Drazen J.M. (2003). Association of a missense mutation in the NOS3 gene with exhaled nitric oxide levels. Am. J. Respir. Crit. Care Med. 168:228-231.
95. Stream J.O., and Grissom C.K. (2008). Update on high-altitude pulmonary edema: Pathogenesis, prevention, and treatment. Wilderness Environ. Med. 19:293-303.
96. Tian C., Gregersen P.K., and Seldin M.F. (2008). Accounting for ancestry: Population substructure and genome-wide association studies. Hum. Mol. Genet. 17:R143-R150.
97. Tiret L., Bonnardeau, A., Poirier O., Ricard S., Marques-Vidal P., Evans A., Arveiler D., Luc G., Kee F., Ducimetiere P., et al. (1994). Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 344:910-913.
98. Tissot van Patot M.C., Leadbetter G., Keyes L.E., Bendrick-Peart J., Beckey V.E., Christians U., and Hackett P. (2005). Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness. J. Appl. Physiol. 98:1626-1629.
99. Tsianos G., Eleftheriou K.I., Hawe E., Woolrich L., Watt M., Watt I., Peacock A., Montgomery H., and Grant S. (2005). Performance at altitude and angiotensin I-converting enzyme genotype. Eur. J. Appl. Physiol. 9:630-633.
100. van Geel P.P., Pinto Y.M., Zwinderman A.H., Henning R.H., van Boven A.J., Jukema J.W., Bruschke A.V.G., Kastelein J.J.P., and van Gilst W.H. (2001). Increased risk for ischaemic events is related to combined RAS polymorphism. Heart. 85:458-462.
101. Wagner D.R., Fargo J.D., Parker D., Tatsugawa K., and Young T.A. (2006). Variables contributing to acute mountain sickness on the summit of Mt. Whitney. Wilderness Environ. Med. 17:221-228.
102. Wald D.S., Law M., and Morris J.K. (2002). Homocysteine and cardiovascular disease: Evidence on causality from a metaanalysis. Br. Med. J. 325:1202.
103. Wang P., Ha A.Y.N., Kidd K.K., Koehle M.S., and Rupert J.L. (2010a). A variant of the endothelial nitric oxide synthase gene (NOS3) associated with AMS susceptibility is less common in the Quechua, a high-altitude native population. High Alt. Med. Biol. 11:27-30.
104. Wang P., Koehle M.S., and Rupert J.L. (2007). Common haplotypes in the b-2 adrenergic receptor gene are not associated with acute mountain sickness susceptibility in Nepalese. High Alt. Med. Biol. 8:206-212.
105. Wang P., Koehle M.S., and Rupert J.L. (2009). Genotype at the missense G894T polymorphism (Glu298Asp) in the NOS3 gene is associated with the susceptibility to acute mountain sickness. High Alt. Med. Biol. 10:261-267.
106. Wang P., Koehle M.S., and Rupert J.L. (2010b). No association between alleles of the bradykinin receptor-B2 gene (BDKRB2) and acute mountain sickness. Exp. Biol. Med. 235:737-740.
107. Wang S.H., Chen Y.C., Kao W.F., Lin Y.J., Chen J.C., Chiu T.F., Hsu T.Y., Chen H.C., and Liu S.W. (2010c). Epidemiology of acute mountain sickness of Jade Mountain, Taiwan: An annual prospective observational study. High Alt. Med. Biol. 11:43-49.
108. Watson C.J., Webb N.J., Bottomley M.J., and Brenchley P.E. (2000). Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: Correlation with variation in VEGF protein production. Cytokine. 12:1232-1235.
109. Weis, J., Haefeli W.E., Gasse C., Hoffmann M.M., Weyman J., Gibbs S., Mansmann U., and Bartsch P. (2003). Lack of evidence for association of high altitude pulmonary edema and polymorphisms of the NO pathway. High Alt. Med. Biol. 4:355-366.
110. Wenger R.H., Stiehl D.P., and Camenisch G. (2005). Integration of oxygen signaling at the consensus HRE. Sci. STKE 2005, re12.
111. Wilson M.H., Newman S., and Imray C.H. (2009). The cerebral effects of ascent to high altitudes. Lancet Neurol. 8:175-191.
112. Wu T., Li S., and Ward M.P. (2005). Tibetans at extreme altitude. Wilderness Environ. Med. 16:47-54.
113. Wu T.Y., Ding S.Q., Liu J.L., Yu M.T., Jia J.H., Duan J.Q., Chai Z.C., Dai R.C., Zhang S.L., Liang B.Z., et al. (2009). Reduced incidence and severity of acute mountain sickness in Qinghai- Tibet railroad construction workers after repeated 7-month exposures despite 5-month low altitude periods. High Alt. Med. Biol. 10:221-232.
114. Xu F., and Severinghau, J.W. (1998). Rat brain VEGF expression in alveolar hypoxia: Possible role in high-altitude cerebral edema. J. Appl. Physiol. 85:53-57.
115. Yaron M., Niermeyer S., Lindgren K.N., Cairns C., Strain J., and Honigman B. (2001). Response of young children to moderate altitude exposure. Wilderness Environ. Med. 12:55-56 [abstract].
116. Yaron M., Niermeyer S., Lindgren K.N., and Honigman B. (2002). Evaluation of diagnostic criteria and incidence of acute mountain sickness in preverbal children. Wilderness Environ. Med. 13:21-26.
117. Yi X., Liang Y., Huerta-Sanchez E., Jin X., Cuo Z.X., Pool J.E., Xu X., Jiang H., Vinckenbosch N., Korneliussen T.S., et al. (2010). Sequencing of 50 human exomes reveals adaptation to high altitude. Science. 329:75-78.
118. Yu L., Quinn D.A., Garg H.G., and Hales C.A. (2005). Cyclindependent kinase inhibitor p27Kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice. Circ. Res. 97:937-945.
119. Zhou F., Wang F., Li F., Yuan J., Zeng H., Wei Q., Tanguay R.M., and Wu T. (2005). Association of hsp70-2 and hsp-hom gene polymorphisms with risk of acute high-altitude illness in a Chinese population. Cell Stress Chap. 10:349-356.
120. Zhu X., Bouzekri N., Southam L., Cooper R.S., Adeyemo A., McKenzie C.A., Luke A., Chen, G., Elston R.C., and Ward R. (2001). Linkage and association analysis of angiotensin Iconverting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am. J. Hum. Genet. 68: 1139-1148.